Thiols, malonaldehyde status in the Turkish and total antioxidant patients with type 2 diabetes mellitus

被引:25
作者
Duman, BS
Öztürk, M
Yilmazer, S
Hatemi, H
机构
[1] Kadir Has Univ, Fac Med, Dept Med Biol & Genet, Istanbul, Turkey
[2] Istanbul Univ, Cerrahpasa Fac Med, Dept Med Biol, Istanbul, Turkey
[3] Turkish Diabet Hosp, Istanbul, Turkey
[4] Istanbul Univ, Cerrahpasa Fac Med, Dept Endocrinol & Metab, Istanbul, Turkey
关键词
D O I
10.1620/tjem.201.147
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Non-insulin-dependent (Type 2) diabetes mellitus (NIDDM) is a risk factor for cardiovascular diseases (CVD). Oxidative stress mechanisms are often reported to be implied in type 2 diabetes mellitus. In order to determine their clinical relevance, we investigated several plasma indicators in the Turkish patients with NIDDM: (1) homocysteine (Hey) and cysteine (Cys) which contribute to increase the risk of atherosclerosis during NIDDM, (ii) glutathione (GSH) and cysteinylglycine (CysGly) resulting from GSH degradation catalyzed by gamma-glutamylcysteine transferase (GGT), (iii) malonaldehyde (MDA) as a marker for lipid peroxidation, and (iv) total antioxidant status (TAS). Our main results were evaluated based on sex and diabetic status. In female patients, plasma concentrations of MDA and Hey were significantly higher than in controls, while GSH levels were significantly lower. In males, a difference between control and diabetic groups was noticed only for Hey, levels being also higher in patients. In the diabetic group, increase in serum glucose concentration was significantly correlated with increased GGT activity. In both controls and diabetic patients, GGT activity was correlated with a raised Cys concentration and a decreased GSH level. In both controls and diabetic patients, there were significant positive correlations between Cys and Hey and between GSH and Hey. We concluded that GSH and MDA levels are clinical indicators for an oxidative process linked to type 2 diabetes mellitus, especially in women.
引用
收藏
页码:147 / 155
页数:9
相关论文
共 41 条
[1]  
ANGELICO F, 1990, WORLD DATA BOOK OBES
[2]   PLASMA SULFHYDRYL-CONTAINING AMINO-ACIDS IN PATIENTS WITH CEREBRAL INFARCTION AND IN HYPERTENSIVE SUBJECTS [J].
ARAKI, A ;
SAKO, Y ;
FUKUSHIMA, Y ;
MATSUMOTO, M ;
ASADA, T ;
KITA, T .
ATHEROSCLEROSIS, 1989, 79 (2-3) :139-146
[3]   Coronary heart disease: Reducing the risk - A worldwide view [J].
Assmann, G ;
Carmena, R ;
Cullen, P ;
Fruchart, JC ;
Jossa, F ;
Lewis, B ;
Mancini, M ;
Paoletti, R .
CIRCULATION, 1999, 100 (18) :1930-1938
[4]   Factors associated with oxidative stress in human populations [J].
Block, G ;
Dietrich, M ;
Norkus, EP ;
Morrow, JD ;
Hudes, M ;
Caan, B ;
Packer, L .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (03) :274-285
[5]   GENDER DIFFERENCES IN A TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC POPULATION WITH RESPECT TO APOLIPOPROTEIN-E PHENOTYPE FREQUENCIES [J].
BOEMI, M ;
JAMES, RW ;
ROMAGNOLI, F ;
GERBER, P ;
POMETTA, D ;
FUMELLI, P .
DIABETOLOGIA, 1993, 36 (03) :229-233
[6]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[7]  
Cao GH, 1998, CLIN CHEM, V44, P1309
[8]  
CARBONNEAU MA, 1991, CLIN CHEM, V37, P1423
[9]   Total radical-trapping antioxidant parameter in NIDDM patients [J].
Ceriello, A ;
Bortolotti, N ;
Falleti, E ;
Taboga, C ;
Tonutti, L ;
Crescentini, A ;
Motz, E ;
Lizzio, S ;
Russo, A ;
Bartoli, E .
DIABETES CARE, 1997, 20 (02) :194-197
[10]   Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus:: a new link between diabetic nephropathy and cardiovascular disease? [J].
Chico, A ;
Pérez, A ;
Córdoba, A ;
Arcelús, R ;
Carreras, G ;
de Leiva, A ;
González-Sastre, F ;
Blanco-Vaca, F .
DIABETOLOGIA, 1998, 41 (06) :684-693